Research Focus

Former Employee. GRADUATE STAFF; NE Medical Student

Recent additions – View all

1. Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: A phase 2 clinical trial

   Journal Article

   Autio, K. A.; Dreicer, R.; Anderson, J.; Garcia, J. A.; Alva, A.; Hart, L. L.; Milowsky, M. I.; Posadas, E. M.; Ryan, C. J.; Graf, R. P.; more...
   JAMA Oncology (2018)

   Fulltext@MSK | Save